Travere Therapeutics Gains Strategic Momentum as Filspari Secures Full FDA Approval for Patients
The pharmaceutical landscape for rare kidney diseases underwent a significant transformation recently as Travere Therapeutics secured a pivotal regulatory victory. The United
by 
Josh Weiner
Josh Weiner